Orgenesis Stock Set to Reverse Split on Wednesday, September 25th (NASDAQ:ORGS)

Shares of Orgenesis Inc. (NASDAQ:ORGS) are scheduled to reverse split on the morning of Wednesday, September 25th. The 1-10 reverse split was announced on Monday, September 23rd. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, September 24th.

Orgenesis Stock Down 24.6 %

NASDAQ ORGS traded down $0.13 during trading on Monday, hitting $0.39. 761,797 shares of the company’s stock were exchanged, compared to its average volume of 180,954. The stock’s 50 day moving average price is $0.70 and its two-hundred day moving average price is $0.63. Orgenesis has a fifty-two week low of $0.25 and a fifty-two week high of $1.08.

Orgenesis (NASDAQ:ORGS) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.23) earnings per share (EPS) for the quarter. The company had revenue of $0.25 million for the quarter.

About Orgenesis

Orgenesis Inc, a biotech company, focuses on cell and gene therapies worldwide. It operates through two segments, Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare network consisting of research institutes and hospitals.